[an error occurred while processing this directive]
|
Novo’s Inhaled
Insulin Is Pulled From Further Research
Inhaled form of insulin fails to
reach test goals, so Novo Nordisk A/S
is pulling the plug.
Aradigm Corp., which is developing
an inhaled form of insulin, said partner
Novo Nordisk A/S is ending a study on
the experimental treatment because it
did not work as well as the injectable
form. Shares fell as much as 37 percent.
The AERx iDMS pulmonary-insulin treatment
failed to reach goals of the study in
Type-1 diabetics, which account for
5 percent to 10 percent of all diabetic
patients in the United States. The trial
was the final of three phases required
for U.S. approval, Aradigm said Friday.
Diabetes is a disease in which the body
doesn't produce or properly use insulin,
a hormone needed to convert sugar and
food into energy.
===========================
Advertisement
Flatulence ... Certain diabetes
drugs stop or delay the absorption
of carbohydrates resulting in
sugars moving into the colon which
causes excess flatus. Normal,
daily flatulence produces 400cc
to 1200cc of gas which is expelled
from the body. Specifically when
nasal and audible detection is
present you or your patient is
often places in a socially awkward
and embarrassing position. Dr.
Seitz said... "Patients with
intestinal gas conditions can
go out to public places without
fear of emitting embarrassing
odors." Rae Seitz M.D.
http://www.diabetesincontrol.com/flatd/index.shtml
|
|
[an error occurred while processing this directive]
|
